Communications Biology (Dec 2020)

Development of a penem antibiotic against Mycobacteroides abscessus

  • Hunter R. Batchelder,
  • Elizabeth Story-Roller,
  • Evan P. Lloyd,
  • Amit Kaushik,
  • Kristina M. Bigelow,
  • Emily C. Maggioncalda,
  • Eric L. Nuermberger,
  • Gyanu Lamichhane,
  • Craig A. Townsend

DOI
https://doi.org/10.1038/s42003-020-01475-2
Journal volume & issue
Vol. 3, no. 1
pp. 1 – 5

Abstract

Read online

Batchelder et al. report a new penem class antibiotic, T405, which exhibits potent activity against M. abscessus and clinical isolates from cystic fibrosis patients. The development of resistance to T405 is inhibited with the addition of a β-lactamase inhibitor, avibactam. Its clinical potential is further demonstrated by T405 displaying a favourable pharmacokinetic profile in mice with an absence of toxicity.